Positive Results for Patisiran in ATTR Amyloidosis Cardiomyopathy ...Middle East

The RNAi therapeutic patisiran improves functional capacity and quality of life in ATTR amyloidosis with cardiomyopathy, topline results of APOLLO-B show. The company will seek an FDA supplemental NDA. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results for Patisiran in ATTR Amyloidosis Cardiomyopathy )

Also on site :

• Conquering Soccer and Arming Warlords
• Pope Leo XIV marks feast day as Vatican launches campaign to help erase its $57-68 million deficit
• Antigovernment protesters clash with riot police in Serbia